Penserra Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13K | Sell |
126
-8,685
| -99% | -$896K | ﹤0.01% | 811 |
|
|
2025
Q1 | $888K | Buy |
8,811
+4,952
| +128% | +$499K | 0.02% | 480 |
|
|
2024
Q4 | $344K | Buy |
3,859
+3,733
| +2,963% | +$333K | 0.01% | 636 |
|
|
2024
Q3 | $10K | Buy |
126
+6
| +5% | +$476 | ﹤0.01% | 890 |
|
|
2024
Q2 | $9K | Hold |
120
| – | – | ﹤0.01% | 935 |
|
|
2024
Q1 | $8K | Sell |
120
-6,655
| -98% | -$444K | ﹤0.01% | 928 |
|
|
2023
Q4 | $390K | Sell |
6,775
-1,425
| -17% | -$82K | 0.01% | 576 |
|
|
2023
Q3 | $432K | Sell |
8,200
-1,114
| -12% | -$58.7K | 0.01% | 560 |
|
|
2023
Q2 | $503K | Buy |
9,314
+9,236
| +11,841% | +$499K | 0.01% | 519 |
|
|
2023
Q1 | $3K | Hold |
78
| – | – | ﹤0.01% | 963 |
|
|
2022
Q4 | $3K | Buy |
+78
| New | +$3K | ﹤0.01% | 1021 |
|
|
2022
Q2 | – | Sell |
-684
| Closed | -$30K | – | 1389 |
|
|
2022
Q1 | $30K | Sell |
684
-306
| -31% | -$13.4K | ﹤0.01% | 1135 |
|
|
2021
Q4 | $42K | Sell |
990
-192
| -16% | -$8.15K | ﹤0.01% | 1063 |
|
|
2021
Q3 | $51K | Buy |
1,182
+682
| +136% | +$29.4K | ﹤0.01% | 1045 |
|
|
2021
Q2 | $21K | Buy |
+500
| New | +$21K | ﹤0.01% | 1133 |
|
|
2019
Q3 | – | Sell |
-3,150
| Closed | -$135K | – | 863 |
|
|
2019
Q2 | $135K | Buy |
+3,150
| New | +$135K | 0.01% | 446 |
|